USE OF GEL WITH BACTERIOPHAGES TO SANITIZE THE NASOPHARYNX IN STAPHYLOCOCCUS AUREUS CARRIERS AMONG THE STAFF OF AN OBSTETRIC FACILITY


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Objective. To investigate the efficacy and safety of gel with bacteriophages for nasopharyngeal sanitation in the medical staff of an obstetric facility in order to prevent nosocomial infections caused by S. aureus. Subjects and methods. The investigation enrolled 55 workers from the Neonatal Departments of the Center and a maternity room who had bacteriologically verified S. aureus carriage. The nasopharynx of the medical workers was sanitized with the gel and bacteriophages Otofag (Mikromir, Russia) for 7 days. Results. Microbiological monitoring showed the efficiency of nasopharyngeal sanitation in 94% of the medical workers in the first control test 1-2 weeks after sanitation and in 75.5% of the examinees in the second control test 1-2 months after this procedure. Adverse events were noted in none of the study participants. Conclusion. Otofag showed its efficacy and safety in sanitizing staphylococcus carriers in the obstetric facilities and may be used for periodic preventive sanitation of the nasopharynx of medical staff.

Texto integral

Acesso é fechado

Sobre autores

Tatiana Priputnevich

Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: priputl@gmail.com
MD, Head of research Department of clinical pharmacology and microbiology Moscow 117997, Ac. Oparina str. 4, Russia

Julia Rodchenko

Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: docrodchenko@mail.ru
physician microbiologist in the Department of clinical pharmacology in Department of clinical pharmacology and microbiology Moscow 117997, Ac. Oparina str. 4, Russia

Lyudmila Lyubasovskaya

Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: labmik@yandex.ru
PhD, Head of Department of clinical pharmacology in Department of clinical pharmacology and microbiology Moscow 117997, Ac. Oparina str. 4, Russia

Valeriy Chubarov

Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: v.chubarov@oparina4.ru
physician epidemiologist in the Department of clinical pharmacology in Department of clinical pharmacology and microbiology Moscow 117997, Ac. Oparina str. 4, Russia

Viktor Zubkov

Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: v_zubkov@oparina4.ru
MD, Head Department of neonatology Moscow 117997, Ac. Oparina str. 4, Russia

Roman Shmakov

Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: r_shmakov@oparina4.ru
MD, Head Physician Moscow 117997, Ac. Oparina str. 4, Russia

Bibliografia

  1. Исмагилова Н.Ф., Кожевникова Ю.П., Соколова Е.В. Сравнительная характеристика носительства золотистого стафилококка у студенток ООМК специальности «Акушерское дело». Успехи современного естествознания. 2014; 6: 146-7
  2. Иванова Н.Ю., Широкова И.Ю., Дмитренко О.А., Ковалишена О.В., Копассовская О.В. Эпидемическое неблагополучие в родильном доме, вызванное метициллинчувствительным Staphylococcus aureus, несущим комплекс генов, кодирующих синтез лейкоцидина Пантона-Валентина. Инфекционные болезни. 2013; ЩПриложение 1): Материалы V ежегодного Всероссийского конгресса по инфекционным болезням. Москва 25-27 марта 2013
  3. Приказ Министерства здравоохранения РФ № 302н «Об утверждении перечней вредных и (или) опасных производственных факторов и работ, при выполнении которых проводятся обязательные предварительные и периодические медицинские осмотры (обследования), и порядка проведения обязательных медицинских осмотров (обследований) работников, занятых на тяжелых работах и на работах с вредными и (или) опасными условиями труда» от 12 апреля 2011 года
  4. Рациональное применение бактериофагов в лечебной и противоэпидемической практике. Федеральные клинические (методические) рекомендации. М.; 2014. 54с
  5. TamarizJ.H., Lezameta L., Guerra H. Phagotherapy faced with Staphylococcus aureus methicilin resistant infections in mice. Rev. Peru. Med. Exp. Salud Publica. 2014; 31(1): 69-77.
  6. Pagava K.I., Metskhvarishvili G.D., Gachechiladze K.K., Korinteli I A., Kho ?le N., Dzuliashvili M.G. Some immunological changes in children with bacterial infections treated with bacteriophages. Georgian Med. News. 2012; 212: 64-9.
  7. Dalmasso M., Hill C., Ross R.P. Exploiting gut bacteriophages for human health. Trends Microbiol. 2014; 22(7): 399-405.
  8. Drilling A., Morales S., Jardeleza C., Vreugde S., Speck P, Wormald PJ. Bacteriophage reduces biofilm of Staphylococcus aureus ex vivo isolates from chronic rhinosinusitis patients. Am. J. Rhinol. Allergy. 2014; 28(1): 3-11.
  9. Patel J.B. Perfomance standarts for antimicrobial susceptibility testing; twenty- fourth informational supplement. 24th ed. Clinical & Laboratory Standards Institute; 2014. 219p.
  10. Melkumyan A., Mitichkin A., BerezJianskiy B., Vamavin O., Alekseev A. Phage sensitivity of multiresistant strains of microorganisms. In: Programme and Abstract 24rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) Barcelona, Spain,10-12 May 2014. ePosterN eP205.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bionika Media, 2016

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies